US Patent 11642308 Ready to use liquid formulation
Patent 11642308 was granted and assigned to Quva Pharma, Inc on May, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Jianping Chen0
Lijie Zhao0
Travis A. Leeah0
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+290 characters)
US Patent 11642308 Ready to use liquid formulation
Article
Disclosed herein is a ready-to-use liquid, injectable formulation comprising lidocaine and epinephrine. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine and epinephrine, as well as methods for using the ready-to-use liquid formulation.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116423080
Date of Patent
May 9, 2023
0Patent Application Number
171479530
Date Filed
January 13, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11642308 Ready to use liquid formulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
